- Home
- Companies
- australasia
- hepatocellular carcinoma
Refine by
Hepatocellular Carcinoma Suppliers Serving Australasia
18 companies found
based inÜmraniye, TURKEY
Vitrosens Biotechnology is a high-tech company in Turkey founded for the development, manufacture, and delivery of in vitro diagnostic devices (IVD) to the world. Vitrosens Biotechnology headquartered in Turkey, by a group of entrepreneurs with a ...
based inNangang Distric, TAIWAN
We are a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of best-in-class novel nanomedicines that combine our proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ...
based inDoylestown, PENNSYLVANIA (USA)
Incorporated in PA in 2011, our MISSION is to translate our circulating cell-free DNA (cfDNA) in urine technology into improved cancer screening and management by liquid biopsy towards our VISION of decreased global cancer mortality. Our proprietary ...
based inOxford, UNITED KINGDOM
Scancell is a clinical stage biopharmaceutical company that is leveraging its proprietary research, built up over many years of studying the human adaptive immune system, to generate truly novel medicines to treat significant unmet needs in cancer ...
based inMerion, PENNSYLVANIA (USA)
Glycotest is a liver disease diagnostics company commercializing new and unique blood tests for life threatening liver cancers and fibrosis-cirrhosis. Founded in 2012 by NetScientific plc on technology originating at the Baruch S. Blumberg ...
based inWoburn, MASSACHUSETTS (USA)
Sirtex is a company specializing in the manufacture of SIR-Spheres® Y-90 resin microspheres, which are medical devices indicated for the treatment of unresectable hepatocellular carcinoma (HCC) and unresectable metastatic liver tumors from primary ...
based inChantilly, VIRGINIA (USA)
Arthus Biosystems is pleased to provide a series of research reagents and kits to help carry out scientific investigations related to methionine cycle, the critical biochemical pathway that is conserved throughout evolution in all organisms. Our SAM ...
based inShirley, NEW YORK (USA)
After decades of research and accumulation, Creative Biolabs has become a leader in the discovery and manufacturing of recombinant antibodies (rAbs), providing the most reliable and qualified services to customers in academia and industry around the ...
Recombinant monoclonal antibody to ENG. It is a human monoclonal antibody that can be potentially used in the treatment of Hepatocellular Carcinoma, Gestational Trophoblastic Neoplasia, Choriocarcinoma, Placental ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Following 1-methyladenosine methylation, upregulation of PPARδ expression regulates cholesterol metabolism and activates Hedgehog signaling pathway, driving liver tumorigenesis[1][2][3].In Vitro:Compared to surrounding tumor tissues, ...
based inDoylestown, PENNSYLVANIA (USA)
ImCare Biotech is a biotechnology company founded in 2011 by Dr. Xuanyong Lu, formerly a professor at Drexel University’s Institute for Biotechnology and Virology. The company’s primary products in development are innovative diagnostic biomarkers as ...
ImCare Biotech is developing a diagnostic kit, Seravue®, for the early detection of liver cancer, which is supported by an SBIR phase II grant from the National Cancer Institute (NCI, ...
based inRichmond, BRITISH COLUMBIA (CANADA)
GenomeMe Lab Inc. is a Vancouver-based biotech company specializing in mouse and rabbit IHC (immunohistochemistry) monoclonal antibodies for clinical diagnostic use. Since our inception in 2017, our goal has been to develop each of the 260+ clinical ...
Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) is an enzyme of the aldo-keto reductase superfamily, and catalyzes the reduction of aliphatic and aromatic aldehydes. AKR1B10 is commonly expressed in adrenal glands, the small intestine, and colon ...
based inCambridge, MASSACHUSETTS (USA)
Myeloid Therapeutics is a leader in the development of mRNA-based immunotherapies, focusing on harnessing and enhancing the natural capabilities of myeloid cells to combat cancer. The company's cutting-edge in vivo engineering platform is designed ...
MT-303 represents the first candidate in a new therapeutic modality targeting hepatocellular carcinoma (HCC). Liver cancer is a prevalent and challenging cancer with over 850,000 new cases diagnosed globally each ...
based inSouth San Francisco, CALIFORNIA (USA)
Senti Bio was founded to create a new generation of smarter medicines that outmaneuver complex diseases using novel and unprecedented approaches. Senti Bio designs and optimizes gene circuits, which are created from novel and proprietary ...
The product profile of SENTI-301 has the potential to promote expansion and persistence of NK cells, and activate and recruit the body’s own immune cells into the solid tumor microenvironment for enhanced anti-tumor activity. ...
based inKalamazoo, MICHIGAN (USA)
Versant Physics provides exceptional quality consulting and software support services to healthcare providers. Our comprehensive line of services includes RSO & Regulatory Support, Clinical Physics Services, Odyssey Software, Personnel Dosimetry ...
based inDallas, TEXAS (USA)
Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past thirty years, Santa Cruz Biotechnology has focused on the ongoing development of research monoclonal antibodies, ...
all-cis-4,7,10,13,16-Docosapentaenoic acid is an unsaturated fatty acid found in fish oils, serving as a Daphnia tenebrosa metabolite, a human metabolite and an algal ...
based inSeoul, SOUTH KOREA
Eutilex is Developing anti-tumor T cell therapy and antibody therapeutics based on its own proprietary immunotherapy technology We set a goal to be a leading company in anti-tumor immunotherapy markets through the technical innovation & early ...
4th generation GPC3 CAR-T shows better efficacy compared to 2nd generation GPC3 CAR-T; Shows better efficacy for tumor clearance than 2nd generation GPC3 CAR-T in vivo; Clear anti-cancer efficacy in an orthotopic model; Smaller number of 4th ...
based inLa Tronche, FRANCE
INOVOTION is a Contract Research Laboratory implementing a unique approach to in vivo evaluation for anticancer drug discovery. Our cutting-edge proprietary technology provides early analysis of your compounds before the classical preclinical stage. ...
based inShipley, UNITED KINGDOM
Our founders have more than 50 years of experience in the field of protein and antibody research. They are experts in this niche market and the main purpose behind the creation of this company was to offer customers with the highest quality ...